News & Perspective

Dec 31, 2012

Dec 31, 2012

FDA approves first med for multidrug-resistant TB

(CIDRAP News) – The US Food and Drug Administration (FDA) today announced its approval of Sirturo (bedaquiline), the first drug developed specifically to treat multidrug-resistant tuberculosis (MDR-TB), saying it must be used in combination with other TB medications.

Dec 17, 2012

Dec 17, 2012

With more surveillance, flu patterns in Africa begin to emerge

(CIDRAP News) – Increased surveillance in recent years has begun to fill in some of the huge information gaps regarding influenza in Africa, which should eventually make it possible to develop or improve public health interventions, according to a big collection of articles published recently in the Journal of Infectious Diseases (JID).

Dec 13, 2012

Dec 13, 2012

Global study notes progress against infectious diseases

(CIDRAP News) – Infectious diseases are causing fewer deaths and illnesses worldwide than two decades ago, with fewer kids dying, but younger and middle-aged adults are bearing more of the overall medical burden, according to a massive multipart study published today in The Lancet.

Oct 18, 2012

Oct 18, 2012

WHO report notes TB progress, areas for concern

(CIDRAP News) – Several developments are having an impact on reducing tuberculosis (TB) infections and deaths in several countries, but the disease's burden is still enormous, and response to multidrug-resistant TB (MDR-TB) remains slow, the World Health Organization (WHO) said yesterday in its latest report on the global TB situation.

Aug 30, 2012

Aug 30, 2012

Researchers find alarming global levels of drug-resistant TB

(CIDRAP News) – A large, eight-nation study today reported worrisome levels of tuberculosis (TB) resistant to first- and second-line drugs, along with higher-than-expected levels of extensively drug-resistant (XDR) TB.

Pages

Sort Results

 

Narrow results

by Topic

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»